Lobbying client

CARDIODX, INC.

Pioneer in the field of cardiovascular genomic diagnostics

Filings
2
Filed by
1
Reported in-house
—
Reported by firms
$30,000

Filings

2 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2018
STRATEGIC MARKETING INNOVATIONS $30,000 reported
Registration
2nd Quarter 2018
STRATEGIC MARKETING INNOVATIONS — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
STRATEGIC MARKETING INNOVATIONS 1 $30,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.